12 completed, 3 unknown, 1 enrolling by invitation, 1 recruiting. 8 Not applicable, 5 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 8 | Completed 5, Suspended 1, Terminated 1, Unknown 1 |
| Phase 1 | 5 | Completed 5 |
Follow Zika: new trials by email Literature Review of Zika trials Research Report on Zika
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Using Digital Technology for the Prevention of Aedes-Borne Diseases in Colombian Communities Full intervention, Partial intervention - Dengue, Zika | Not applicable | Completed | University of Freiburg | 900 | 2026-03-26 | 2026-04-08 |
| Xpert® Tropical Fever Test on GeneXpert® Edge X System Xpert Tropical Fever test - Malaria Fever, Zika | Enrolling by invitation | Cepheid | 2500 | 2025-08-18 | 2026-04-09 | |
| Testing Combined IIT-SIT to Control Mosquito-Borne Diseases At Scale Wolbachia induced incompatible mating, Standard traditional chemical mosquito control - Dengue, Zika | Not applicable | Terminated | Michigan State University | 15243 | 2024-05-28 | 2026-03-19 |
| Phase 1 Trial to Assess the Safety and Immunogenicity of an Inactivated, Adjuvanted Whole Zika Virus Vaccine Candidate (VLA1601) in Healthy Adults VLA1601, CpG 1018®, 3M-052-AF - Zika, Zika Virus Infection | Phase 1 | Completed | Valneva Austria GmbH | 150 | 2024-03-25 | 2026-03-09 |
| Population Immunity AgaiNst mosquitO-borne Diseases in Vanuatu Blood collection - Arbovirus Disease, Zika | Not applicable | Completed | Institut Pasteur | 1122 | 2022-10-17 | 2024-05-23 |
| Baromètre Santé Adulte 2021-2022 Blood sample - Diabetes, Hypercholesterolemia | Not applicable | Suspended | Agence Sanitaire et Sociale de Nouvelle Calédonie | 5471 | 2021-07-26 | 2022-02-01 |
| Virological and Immunological Determinants of Arbovirus Infection in New Caledonia Blood sample collection - Arbovirus Infections, Zika | Not applicable | Unknown | Institut Pasteur | 250 | 2021-02-15 | 2024-05-23 |
| Sylvatic Transmission of Zika, Dengue, and Chikungunya Viruses in Thailand and Cambodia Dengue Fever, Zika | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 300 | 2021-02-08 | 2024-04-26 | |
| Infection Tracking in Travellers. The Project Aims to Identify Profiles of Travel-associated Illness and to Follow up on Long-term Sequelae of Arboviral Infections and Malaria Observational study - Travel-Related Illness, Malaria | Unknown | Patricia Schlagenhauf | 10000 | 2021-01-30 | 2020-12-17 | |
| Quantifying the Epidemiological Impact of Targeted Indoor Residual Spraying on Aedes-borne Diseases Targeted Indoor Residual Spraying (TIRS) - Aedes-borne Diseases, Dengue | Not applicable | Completed | Emory University | 4461 | 2020-11-03 | 2025-09-18 |
| Research Study to Assess New Chikungunya and Zika Vaccines in Healthy Adults in Mexico. CHIK low dose, CHIK mid dose, CHIK high dose - Chikungunya, Zika | Phase 1 | Completed | University of Oxford | 120 | 2020-10-23 | 2022-03-23 |
| Genetic Evolution of Arboviruses in New Caledonia Between 1995 and 2024 and Impact of Wolbachia Arbovirus Infections, Dengue | Unknown | Institut Pasteur | 600 | 2020-07-17 | 2024-05-23 | |
| Safety and Immunogenicity of a Candidate ZIKV Vaccine (ZIKA001) ChAdOx1 Zika - Zika | Phase 1 | Completed | University of Oxford | 24 | 2019-10-21 | 2022-05-18 |
| International Cohort Study of Children Born to Women Infected With Zika Virus During Pregnancy Zika, Neurodevelopmental Abnormality | Completed | Westat | 272 | 2019-06-12 | 2022-04-22 | |
| Sustainable Reduction of Dengue in Colombia: Vector Breeding Site Intervention With an Insecticidal Coating Insecticide Coating INESFLY - Dengue, Vector Borne Diseases | Not applicable | Completed | Rocio Cardenas Sanchez | 35000 | 2019-02-04 | 2024-05-13 |
| Defining Skin Immunity of a Bite of Key Insect Vectors in Humans One vector feeding, Four vector feeding - Zika, Dengue | Not applicable | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 95 | 2018-09-05 | 2021-12-08 |
| Zika Virus Purified Inactivated Vaccine (ZPIV) Accelerated Vaccination Schedule Study Zika Virus Purified Inactivated Vaccine, Placebo - Zika | Phase 1 | Completed | Kathryn Stephenson | 36 | 2016-12-08 | 2018-08-23 |
| GLS-5700 in Dengue Virus Seropositive Adults GLS-5700, Placebo - Healthy, Zika | Phase 1 | Completed | GeneOne Life Science, Inc. | 160 | 2016-08-01 | 2022-01-20 |
| Screening for LID Clinical Studies Unit Healthy Volunteer Protocols Zika, Influenza | Recruiting | National Institute of Allergy and Infectious Diseases (NIAID) | 5000 | 2011-07-20 | 2026-11-12 |
Zika Virus Infection (19) · Chikungunya Fever (13) · Dengue (12) · Malaria (4) · Arbovirus Infections (3) · Influenza, Human (2) · Mosquito-Borne Diseases (2) · Ross River Virus Infection (2) · Severe Acute Respiratory Syndrome (2) · Vector Borne Diseases (2) · COVID-19 (1) · Chronic Disease (1) · Diabetes Mellitus (1) · Diarrhea (1) · Eye Abnormalities (1)
Flaviviridae Infections (19) · Flavivirus Infections (19) · Infections (19) · RNA Virus Infections (19) · Virus Diseases (19) · Mosquito-Borne Diseases (17) · Vector Borne Diseases (17) · Arbovirus Infections (16) · Alphavirus Infections (13) · Togaviridae Infections (13) · Hemorrhagic Fevers, Viral (12) · Parasitic Diseases (4) · Protozoan Infections (4) · Respiratory Tract Diseases (4) · Respiratory Tract Infections (4)
Blood Specimen Collection (2) · 1018 oligonucleotide (1) · GLS-5700 vaccine (1) · Observation (1)
Institut Pasteur (3) · National Institute of Allergy and Infectious Diseases (NIAID) (3) · University of Oxford (2) · Agence Sanitaire et Sociale de Nouvelle Calédonie (1) · Cepheid (1) · Emory University (1) · GeneOne Life Science, Inc. (1) · Kathryn Stephenson (1) · Michigan State University (1) · Patricia Schlagenhauf (1) · Rocio Cardenas Sanchez (1) · University of Freiburg (1) · Valneva Austria GmbH (1) · Westat (1)
United States (5) · Colombia (3) · Mexico (3) · Germany (2) · New Caledonia (2) · Puerto Rico (2) · Brazil (1) · Cambodia (1) · France (1) · Peru (1) · Switzerland (1) · United Kingdom (1) · Vanuatu (1)
Myrielle Dupont-Rouzeyrol, PhD (3) · Matthew J Memoli, M.D. (2) · Adrian V Hill, DPhill FRCP (1) · Axel Kroeger, Prof. Dr. (1) · Christina Yek, M.D. (1) · Deolinda MF Scalabrin, MD, PhD (1) · Gonzalo Vazquez Professor Prokopec, PhD (1) · Gonzalo Vazquez Prokopec, MD (1) · Maria Elisabeth L Moreira, MD (1) · Marisa M. Mussi-Pinhata, MD, MD (1) · Max Petzold, Prof. Dr. (1) · Rocio Cardenas, Research Dr. (1) · Winfried Kern, Prof. Dr. (1)
PMID 33422034, PMID 37254133, PMID 29217375, PMID 32618279, PMID 33686914, PMID 34529649, PMID 35255839, PMID 36384430, PMID 38794811, PMID 39067885, PMID 39543943, PMID 41061233, PMID 41260318, PMID 42552527, PMID 42617628
U01AI148069 (1)